A strain of hybridoma capable of stably excreting anti-URG11 monoclonal antibody
A monoclonal antibody, hybridoma cell technology, applied in the field of hybridoma cells, can solve problems such as unsatisfactory clinical effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0013] 1. Antigen: According to published literature (Lian Z, Liu J, Li L, Li X, TufanNL, Clayton M, Wu MC, Wang HY, Arbuthnot P, Kew M, and FeitelsonMA: Upregulated expression of a unique gene by hepatitis The polypeptide sequence (HPPDGSFSTFHKGPQPLEDPC) in B_antigen promotes hepatocellular growth and tumorigenesis.Neoplasia2003; 5:229-244.) is artificially synthesized as shown in Figure 1, and the polypeptide is linked to hemocyanin (peptide-KLH) or bovine Serum protein (peptide-BSA), and the peptide linked to KLH as the antigen.
[0014] 2. Immunization: BALB / C mice (4-8 weeks old, female) were immunized with KLH-linked polypeptides.
[0015] The first immunization: take 0.5ml peptide-KLH (concentration: 240ug / ml) and mix it with an equal volume of Freund's complete adjuvant, and inject BALB / C mice subcutaneously at multiple points;
[0016] The second immunization: After 3 weeks, take 0.5ml peptide-KLH (concentration: 240ug / ml) and mix it with an equal volume of Freund's ...
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com